Update shared on 07 Nov 2025
Fair value Decreased 0.36%Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.
What's in the News
- MetLife and Alight announced a strategic collaboration to offer institutional income annuities through the Alight Worklife platform. This enables plan participants to convert savings into predictable retirement income (Key Developments).
- Empathy and MetLife are launching Leave Support, a digital platform to assist employees through all aspects of taking a leave of absence. This complements MetLife's My Leave Navigator solution (Key Developments).
- MetLife introduced a new Cancer Support benefit within its Critical Illness Insurance, partnering with Private Health Management to provide personalized counseling and expert care coordination for employees diagnosed with cancer (Key Developments).
- MetLife announced it will redeem all outstanding shares of its Series G Preferred Stock on September 15, 2025, with regular dividends paid separately prior to redemption (Key Developments).
Valuation Changes
- The consensus analyst price target has decreased slightly from $93.33 to $93.00.
- The discount rate has fallen modestly from 7.72 percent to 7.46 percent.
- Revenue growth projections have risen from 4.74 percent to 5.66 percent.
- The net profit margin is almost unchanged, moving marginally from 7.55 percent to 7.53 percent.
- The future P/E ratio is lower, declining from 10.85x to 10.35x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.